19 December 2016
Universal Biosensors acquires the Hemostasis Reference Laboratory business of LifeLabs to meet increased production demands of Siemen’s Xprecia StrideTM test strips
Universal Biosensors, Inc (ASX: UBI) has today announced that a wholly-owned Canadian operating subsidiary has signed an agreement with LifeLabs LP (LifeLabs) to acquire the assets of LifeLabs’ Hemostasis Reference Laboratory business (HRL) in preparation for future increased production requirements of Siemens’ Xprecia StrideTM test strips.
The HRL business has provided high-quality coagulation testing and calibration services to international customers for more than 20 years, including 5 years of services for UBI. HRL has one of the most diverse offerings of specialised coagulation services in the world. Its laboratory currently has 16 different coagulation analyzers available, representing every major manufacturer for a very diverse list of testing options. The HRL business is based out of leased offices in Canada and has approximately 14 employees who will transfer to Universal Biosensors’ wholly-owned Canadian …